» Articles » PMID: 23171222

PER3 and ADORA2A Polymorphisms Impact Neurobehavioral Performance During Sleep Restriction

Overview
Journal J Sleep Res
Specialty Psychiatry
Date 2012 Nov 23
PMID 23171222
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of the study was to determine whether ADORA2A or PER3 polymorphisms contribute to individual responsivity to sleep restriction. Nineteen healthy adults (ages 18-39, 11 males, 8 females) underwent sleep restriction (SR) which consisted of seven nights of 3 h time in bed (TIB) (04:00-07:00). SR was preceded by seven in-laboratory nights of 10 h TIB (21:00-07:00) and followed by three nights of 8 h TIB (23:00-07:00). Volunteers underwent psychomotor vigilance, objective alertness, and subjective sleepiness assessments throughout. Volunteers were genotyped for the PER3 VNTR polymorphism (PER3(4/4) n = 7; PER3(4/5) n = 10; PER3(5/5) n = 2) and the ADORA2A c.1083T>C polymorphism, (ADORA2A(C) (/T) n = 9; ADORA2A(T) (/T) n = 9; ADORA2A(C) (/C) n = 1) using polymerase chain reaction (PCR). Separate mixed-model anovas were used to assess contributions of ADORA2A and PER3 polymorphisms. Results showed that PER3(4/4) and ADORA2A(C/T) individuals expressed greater behavioral resiliency to SR compared to PER(4/5) and ADORA2A(T/T) individuals. Our findings contrast with previously reported non-significant effects for the PER3 polymorphism under a less challenging sleep restriction regimen (4 h TIB per night for five nights). We conclude that PER3 and ADORA2A polymorphisms become more behaviorally salient with increasing severity and/or duration of sleep restriction (based on psychomotor vigilance). Given the small sample size these results are preliminary and require replication.

Citing Articles

TCM-Suite: A comprehensive and holistic platform for Traditional Chinese Medicine component identification and network pharmacology analysis.

Yang P, Lang J, Li H, Lu J, Lin H, Tian G Imeta. 2024; 1(4):e47.

PMID: 38867910 PMC: 10989960. DOI: 10.1002/imt2.47.


Genetic Markers of Differential Vulnerability to Sleep Loss in Adults.

Casale C, Goel N Genes (Basel). 2021; 12(9).

PMID: 34573301 PMC: 8464868. DOI: 10.3390/genes12091317.


Genetic Polymorphism of Is Associated With the Risk of Epilepsy and Predisposition to Neurologic Comorbidity in Chinese Southern Children.

Fan X, Chen Y, Li W, Xia H, Liu B, Guo H Front Neurosci. 2020; 14:590605.

PMID: 33262686 PMC: 7686584. DOI: 10.3389/fnins.2020.590605.


A Topological Cluster of Differentially Regulated Genes in Mice Lacking PER3.

van der Veen D, Laing E, Bae S, Johnston J, Dijk D, Archer S Front Mol Neurosci. 2020; 13:15.

PMID: 32116548 PMC: 7031657. DOI: 10.3389/fnmol.2020.00015.


Risk of excessive sleepiness in sleep restriction therapy and cognitive behavioral therapy for insomnia: a randomized controlled trial.

Cheng P, Kalmbach D, Fellman-Couture C, Arnedt J, Cuamatzi-Castelan A, Drake C J Clin Sleep Med. 2020; 16(2):193-198.

PMID: 31992407 PMC: 7053018. DOI: 10.5664/jcsm.8164.